Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARNET vs FOSFOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARNET vs FOSFOMYCIN: Safety Overview

Metric FOSCARNET FOSFOMYCIN
Total FAERS Reports 2,057 828
Deaths Reported 605 128
Death Rate 29.4% 15.5%
Hospitalizations 608 407
Average Patient Age 41.8 yrs 55.3 yrs
% Female Patients 40.6% 57.3%
FDA Approval Date Apr 21, 2021 Oct 22, 2025
Manufacturer Hikma Pharmaceuticals USA Inc. Meitheal Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription